Abnormal DNA methylation in skin lesions and PBMCs of patients with psoriasis vulgaris

Journal of Dermatological Science

Volumn 60, Issue 1, 2010, Pages 40-42

  Zhang, Peng ^a   Su, Yuwen ^a   Chen, Huan ^a   Zhao, Ming ^a   Lu, Qianjin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; GENOMIC DNA; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 8; MESSENGER RNA; METHYL CPG BINDING PROTEIN; METHYL CPG BINDING PROTEIN 1; METHYL CPG BINDING PROTEIN 2; METHYL CPG BINDING PROTEIN 3; METHYL CPG BINDING PROTEIN 4; UNCLASSIFIED DRUG;

ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA METHYLATION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; OBSERVER VARIATION; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROMOTER REGION; PSORIASIS VULGARIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN BIOPSY; SKIN DEFECT;

ADULT; CYTOKINES; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DNA-BINDING PROTEINS; DOWN-REGULATION; EPIGENESIS, GENETIC; HUMANS; METHYL-CPG-BINDING PROTEIN 2; MIDDLE AGED; MONOCYTES; PROMOTER REGIONS, GENETIC; PSORIASIS; SKIN; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 77957020785     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2010.07.011     Document Type: Letter

References (10)

1. Li Y., Sawalha A.H., Lu Q. Aberrant DNA methylation in skin diseases. J Dermatol Sci 2009, 54:143-149.
2. Gündüz K., Demireli P., Vatansever S., Inanir I. Examination of bcl-2 and p53 expressions and apoptotic index by TUNEL method in psoriasis. J Cutan Pathol 2006, 33:788-792.
3. Luo Y., Li Y., Su Y., Yin H., Hu N., Wang S., et al. Abnormal DNA methylation in T cells from patients with subacute cutaneous lupus erythematosus. Br J Dermatol 2008, 159:827-833.
4. Rountree M.R., Bachman K.E., Herman J.G., Baylin S.B. DNA methylation, chromatin inheritance, and cancer. Oncogene 2001, 20:3156-3165.
5. Okubo Y., Koga M. Peripheral blood monocytes in psoriatic patients overproduce cytokines. J Dermatol Sci 1998, 17:223-232.
6. Brody I. Dermal and epidermal involvement in the evolution of acute eruptive guttate psoriasis vulgaris. J Invest Dermatol 1984, 82:465-470.
7. Hendrich B., Bird A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol 1998, 18:6538-6547.
8. Marshall C.J. Tumor suppressor genes. Cell 1991, 64:313-326.
9. Chen M., Chen Z.Q., Cui P.G., Yao X., Li Y.M., Li A.S., et al. The methylation pattern of p16INK4a gene promoter in psoriatic epidermis and its clinical significance. Br J Dermatol 2008, 158:987-993.
10. Zhang Y., Xiong Y., Yarbrough W.G. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 1998, 92:725-734.